FR2305977B1 - - Google Patents

Info

Publication number
FR2305977B1
FR2305977B1 FR7609448A FR7609448A FR2305977B1 FR 2305977 B1 FR2305977 B1 FR 2305977B1 FR 7609448 A FR7609448 A FR 7609448A FR 7609448 A FR7609448 A FR 7609448A FR 2305977 B1 FR2305977 B1 FR 2305977B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7609448A
Other versions
FR2305977A1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Otsuka Pharmaceutical Co Ltd
Original Assignee
Otsuka Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Pharmaceutical Co Ltd filed Critical Otsuka Pharmaceutical Co Ltd
Publication of FR2305977A1 publication Critical patent/FR2305977A1/fr
Application granted granted Critical
Publication of FR2305977B1 publication Critical patent/FR2305977B1/fr
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Indole Compounds (AREA)
  • Pyrrole Compounds (AREA)
FR7609448A 1975-04-01 1976-04-01 Solution parenterale d'amino-acides Granted FR2305977A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP50040072A JPS51115909A (en) 1975-04-01 1975-04-01 A process for preparing amino acid parenteral injection mixed with a r educing sugar

Publications (2)

Publication Number Publication Date
FR2305977A1 FR2305977A1 (fr) 1976-10-29
FR2305977B1 true FR2305977B1 (fr) 1978-09-01

Family

ID=12570712

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7609448A Granted FR2305977A1 (fr) 1975-04-01 1976-04-01 Solution parenterale d'amino-acides

Country Status (11)

Country Link
US (1) US4085207A (fr)
JP (1) JPS51115909A (fr)
BE (1) BE840227A (fr)
CA (1) CA1052699A (fr)
CH (1) CH618849A5 (fr)
DE (1) DE2614092B2 (fr)
ES (1) ES446895A1 (fr)
FR (1) FR2305977A1 (fr)
GB (1) GB1477624A (fr)
NL (1) NL184148C (fr)
SE (1) SE440451B (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4210637A (en) * 1978-07-31 1980-07-01 Massachusetts Institute Of Technology Composition and method for suppressing appetite for calories as carbohydrates
JPS5536457A (en) * 1978-09-08 1980-03-14 Ajinomoto Co Inc Amino acid infusion
CA1257131A (fr) * 1984-07-27 1989-07-11 John Y. Park Compose pour nutrition parenterale et enterale totale
GB8500862D0 (en) * 1985-01-14 1985-02-20 Tate & Lyle Plc Composition
US4639465A (en) * 1985-08-30 1987-01-27 Commonwealth Medical Corporation Of America Method and composition for relieving pain
DE3601398A1 (de) * 1986-01-18 1987-07-23 Fresenius Ag Verwendung von oligopeptiden zur behandlung von cerebralen stoerungen
JPH0435507U (fr) * 1990-07-20 1992-03-25
ES2264437T3 (es) * 2000-01-18 2007-01-01 Ajinomoto Co., Inc. Remedios para la hepatitis que contienen alanina y glicina.

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2411897A (en) * 1943-01-02 1946-12-03 Sterling Drug Inc Pharmaceutical solution
DE1024325B (de) * 1952-10-31 1958-02-13 Colgate Palmolive Co Verfahren zum Konservieren von Lebensmitteln
US3080234A (en) * 1960-12-06 1963-03-05 Pfizer & Co C Method of improving the efficiency of amino acid diets
US3697287A (en) * 1969-01-28 1972-10-10 Morton Norwich Products Inc Amino acid food composition

Also Published As

Publication number Publication date
BE840227A (fr) 1976-07-16
CH618849A5 (fr) 1980-08-29
US4085207A (en) 1978-04-18
NL7603426A (nl) 1976-10-05
NL184148B (nl) 1988-12-01
JPS51115909A (en) 1976-10-13
CA1052699A (fr) 1979-04-17
AU1247376A (en) 1977-10-06
FR2305977A1 (fr) 1976-10-29
DE2614092A1 (de) 1976-10-14
GB1477624A (en) 1977-06-22
SE440451B (sv) 1985-08-05
JPS5624647B2 (fr) 1981-06-08
ES446895A1 (es) 1977-10-01
DE2614092B2 (de) 1978-02-23
SE7603837L (sv) 1976-10-02
NL184148C (nl) 1989-05-01

Similar Documents

Publication Publication Date Title
FR2297502B3 (fr)
CH603839A5 (fr)
CH1132075A4 (fr)
BG22426A1 (fr)
BG21450A1 (fr)
BG22555A1 (fr)
BG22886A1 (fr)
BG26504A3 (fr)
CH604125A5 (fr)
CH22175A4 (fr)
CH459576A4 (fr)
CH563879A5 (fr)
CH576867A5 (fr)
CH583875A5 (fr)
CH584777A5 (fr)
CH585623A5 (fr)
CH586541A5 (fr)
CH589437A5 (fr)
CH592193A5 (fr)
CH592199B5 (fr)
CH592886A5 (fr)
CH592961A5 (fr)
CH593144A5 (fr)
CH594131A5 (fr)
CH594370A5 (fr)